CytomX Therapeutics (CTMX) Current Taxes (2017 - 2019)

CytomX Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $13.4 million for Q1 2019.

• Quarterly Current Taxes rose 1192.17% year-over-year to $13.4 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $13.4 million (up 1192.17% YoY) and the FY2018 annual result came in at $13.3 million, up 1333800.0% from the prior year.
• Current Taxes was $13.4 million for Q1 2019 at CytomX Therapeutics, roughly flat from $13.3 million in the prior quarter.
• Across five years, Current Taxes topped out at $13.4 million in Q1 2019 and bottomed at $1000.0 in Q4 2017.
• A 3-year average of $5.9 million and a median of $3.8 million in 2018 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2018 — Current Taxes jumped 1333800.0% — and 2019, when it jumped 1192.17%.
• CytomX Therapeutics' Current Taxes stood at $1000.0 in 2017, then soared by 1333800.0% to $13.3 million in 2018, then rose by 0.26% to $13.4 million in 2019.
• Business Quant data shows CTMX's Current Taxes at $13.4 million in Q1 2019, $13.3 million in Q4 2018, and $5.0 million in Q3 2018.